Literature DB >> 7768638

Retinoic acid induced death of ovarian carcinoma cells correlates with c-myc stimulation.

G Krupitza1, W Hulla, H Harant, E Dittrich, E Kallay, H Huber, T Grunt, C Dittrich.   

Abstract

In the ovarian adenocarcinoma subline N.I, all-trans retinoic acid (ATRA) induced substantial cell death. This response was elicited only at decreased serum levels. Exposure of N.I cells to increasing concentrations of ATRA was accompanied by a considerable up-regulation of c-myc transcript levels that correlated with the rate of cell killing, which itself was an active process as judged by sustained transcriptional expression. ATRA-triggered rounding and detaching of single cells from the substratum was accompanied by degradation of genomic DNA. We show that the N.I model cell line, which is otherwise highly ATRA-resistant, can undergo an ATRA-triggered suicide program when serum is limited. The accompanying c-myc up-regulation seems to be mediated by retinoic-acid-receptor-independent pathways involving membrane-associated phospholipases instead, because manoalide partly suppressed c-myc induction by ATRA but left constitutive c-myc expression unaffected.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7768638     DOI: 10.1002/ijc.2910610511

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Promising potency of retinoic acid-poly(ethylene glycol)-thiol gold nanoparticle conjugates for cervical cancer treatment.

Authors:  Li Ye; Qian Song
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Cyclooxygenase-2 knockdown using retinoic acid chalcone (RAC), a promising therapeutic strategy for colon cancer.

Authors:  Chao Jiang; Qiong Wang; Zhe Xu; Wei-Su Li; Che Chen; Xue-Quan Yao; Fu-Kun Liu
Journal:  Am J Cancer Res       Date:  2015-05-15       Impact factor: 6.166

3.  Retinoid-induced histone deacetylation inhibits telomerase activity in estrogen receptor-negative breast cancer cells.

Authors:  Sharla M O Phipps; William K Love; Teresa White; Lucy G Andrews; Trygve O Tollefsbol
Journal:  Anticancer Res       Date:  2009-12       Impact factor: 2.480

4.  Retinoic acid‑incorporated glycol chitosan nanoparticles inhibit the expression of Ezh2 in U118 and U138 human glioma cells.

Authors:  Hu-Chen Lu; Jun Ma; Zong Zhuang; Yao Zhang; Hui-Lin Cheng; Ji-Xin Shi
Journal:  Mol Med Rep       Date:  2015-09-07       Impact factor: 2.952

5.  Bexarotene-induced cell death in ovarian cancer cells through Caspase-4-gasdermin E mediated pyroptosis.

Authors:  Tatsuya Kobayashi; Akira Mitsuhashi; Piao Hongying; Masashi Shioya; Katsushi Kojima; Kyoko Nishikimi; Kinnosuke Yahiro; Makio Shozu
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

6.  All-trans retinoic acid-incorporated nanoparticles of deoxycholic acid-conjugated dextran for treatment of CT26 colorectal carcinoma cells.

Authors:  Young Il Jeong; Kyu Don Chung; Da Hye Kim; Yoon Hyuk Kim; Yeon Soo Lee; Ki Choon Choi
Journal:  Int J Nanomedicine       Date:  2013-01-30

7.  Genes related to growth and invasiveness are repressed by sodium butyrate in ovarian carcinoma cells.

Authors:  G Krupitza; S Grill; H Harant; W Hulla; T Szekeres; H Huber; C Dittrich
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

8.  Effects of retinoic acid and fenretinide on the c-erbB-2 expression, growth and cisplatin sensitivity of breast cancer cells.

Authors:  E Dittrich; M Offterdinger; S M Schneider; Ch Dittrich; H Huber
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

9.  Autocrine self-elimination of cultured ovarian cancer cells by tumour necrosis factor alpha (TNF-alpha).

Authors:  I Simonitsch; G Krupitza
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

Review 10.  Targeting Aldehyde Dehydrogenases to Eliminate Cancer Stem Cells in Gynecologic Malignancies.

Authors:  Vaishnavi Muralikrishnan; Thomas D Hurley; Kenneth P Nephew
Journal:  Cancers (Basel)       Date:  2020-04-13       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.